Hormone Therapy Doesn't Protect Heart

Therapy May Cause Adverse Reactions In Heart Patients

RALEIGH, N.C. -- Hormone replacement therapy helps women cope with the hot flashes and sleepless nights associated with menopause. It has also been used to protect women's hearts after menopause, but new research has doctors questioning that belief.

HEART DISEASE Virtual Heart Heart Risk Test Menu Maker Risk Factors Warning Signs Treatments Heart-Healthy Diet Know Your Heart Women and Heart Health Family History Of Disease? RESOURCES American Heart Association CDC Cardiovascular Heart Program National Heart, Lung, and Blood Institute

Kathy Sullivan went through menopause at age 49. Seven years later, she is still experiencing symptoms.

"I've had the sleep deprivation, hot flashes that you're unsure you're ever going to stop having them," she said.

Nearly 2 million women reach menopause every year. Most symptoms resolve within a few years whether or not they are treated, but many women use hormone therapy to replace the estrogen their body no longer makes. Some with heart disease also take it to reduce their risk of heart attack.

In 1998, the heart and estrogen/progestin replacement study (HERS) found that in the short-term, hormone replacement therapy did not protect women with heart disease from heart attacks. Still, there was the belief that over time, HRT could have a protective effect on the heart.

Now, a follow-up study that included more than 2,000 women found that is not the case.

The study, led by researchers at the University of California in San Francisco, found that HRT does not reduce the risk of heart attack or death. The results are published in Wednesday's issue of the Journal of the American Medical Association

"After seven years, there was no benefit to hormone therapy; that is, the risk of heart attack or dying a coronary death was exactly the same in the women who had taken hormones and the women who had taken the placebo," researcher Dr. Deborah Grady said.

Hormone therapy actually produced adverse effects in women with heart disease, including gall bladder disease and blood clots in the legs and lungs, according to the study.

Duke University participated in both parts of the HERS trial. Dr. Charles Hammond said it is important to realize that the findings do not apply to the majority of women. Only 6 percent of women who start hormone replacement have heart disease.

"Women in the HERS study by the end of the trial averaged 71 years of age. The average patient that starts HRT is about 51," he said.

For now, most experts agree that HRT is not a good idea for heart patients, but for other women, it is a discussion they should have with their doctor.

Copyright 2002 by KSAT.com. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.